Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04ORV
|
||||
| Former ID |
DNC004753
|
||||
| Drug Name |
Des-AA1,2,5,12,13-[D-Trp8]SRIF
|
||||
| Indication | Discovery agent | Investigative | [539291] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C60H78N12O11S2
|
||||
| Canonical SMILES |
CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O<br />)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=<br />C4)CC5=CC=CC=C5)CCCCN)N)C(=O)O)CC6=CC=CC=C6)O
|
||||
| InChI |
1S/C60H78N12O11S2/c1-36(73)51-59(81)70-48(31-39-21-9-4-10-22-39)57(79)71-50(60(82)83)35-85-84-34-42(63)52(74)65-44(25-13-15-27-61)53(75)67-46(29-37-17-5-2-6-18-37)55(77)68-47(30-38-19-7-3-8-20-38)56(78)69-49(32-40-33-64-43-24-12-11-23-41(40)43)58(80)66-45(54(76)72-51)26-14-16-28-62/h2-12,17-24,33,36,42,44-51,64,73H,13-16,25-32,34-35,61-63H2,1H3,(H,65,74)(H,66,80)(H,67,75)(H,68,77)(H,69,78)(H,70,81)(H,71,79)(H,72,76)(H,82,83)/t36-,42-,44-,45+,46-,47+,48+,49+,50+,51-/m1/s1
|
||||
| InChIKey |
ANCUAJMQRRZZNC-JFMJRBFYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor type 3 | Target Info | Inhibitor | [527385] | |
| Somatostatin receptor type 5 | Target Info | Inhibitor | [527385] | ||
| Somatostatin receptor type 4 | Target Info | Inhibitor | [527385] | ||
| Somatostatin receptor type 2 | Target Info | Inhibitor | [527385] | ||
| Somatostatin receptor 1 | Target Info | Inhibitor | [527385] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| PathWhiz Pathway | Gastric Acid Production | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.